Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125476
Filing Date
2024-11-12
Accepted
2024-11-12 16:20:44
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tsbx-20240930.htm   iXBRL 10-Q 2916798
2 EX-31.1 tsbx-ex31_1.htm EX-31.1 13078
3 EX-31.2 tsbx-ex31_2.htm EX-31.2 13203
4 EX-32.1 tsbx-ex32_1.htm EX-32.1 9029
5 GRAPHIC img127456990_0.jpg GRAPHIC 202598
  Complete submission text file 0000950170-24-125476.txt   11026203

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20240930.xsd EX-101.SCH 1519044
77 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20240930_htm.xml XML 1720770
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41747 | Film No.: 241448577
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)